Aniya Y, Anders M W
Biochem Pharmacol. 1985 Jan 15;34(2):249-55. doi: 10.1016/0006-2952(85)90132-7.
The effect of chloroform treatment on the hepatic glutathione S-transferases was studied in phenobarbital-treated rats. The apparent isozymic composition of glutathione S-transferases in hepatic cytosol was changed after chloroform treatment. Glutathione S-transferases AA, A, B, C, and D + E were observed in hepatic cytosol from untreated rats; in contrast, the catalytic activity associated with basic glutathione S-transferases, such as AA, A, B, and C, decreased with time after chloroform treatment. Glutathione S-transferase B was not detectable 2 hr after chloroform treatment, and glutathione S-transferases AA and C were scarcely detectable after 5 hr. Twenty-four hours after chloroform treatment, glutathione S-transferases A and C were clearly detectable as was D + E and a small amount of B. Hepatic cytosolic glutathione S-transferase activity was decreased by chloroform treatment, and reached a minimum at 5 hr after treatment. Corresponding to the decrease of hepatic cytosol glutathione S-transferase activity, serum glutathione S-transferase activity was elevated maximally 5 hr after chloroform treatment and returned to almost normal by 24 hr. Treatment of rats with SKF 525-A or cysteine inhibited the chloroform-induced elevation of serum glutathione S-transferase activity. The chromatographic properties of the glutathione S-transferases present in serum were similar to glutathione S-transferase D + E. Furthermore, after incubation of partially purified cytosolic glutathione S-transferases with chloroform in the presence of hepatic microsomes and NADPH, only transferase D + E was detected. The addition of bilirubin to partially purified cytosolic glutathione S-transferase decreased the basic character of glutathione S-transferases B and C. In conclusion, chloroform caused a release of hepatic cytosolic glutathione S-transferases into serum. Both the active metabolite of chloroform, which was produced by the microsomal cytochrome P-450 system, and bilirubin, which was increased by chloroform treatment, played roles in altering the properties of the glutathione S-transferases.
在经苯巴比妥处理的大鼠中研究了氯仿处理对肝脏谷胱甘肽S-转移酶的影响。氯仿处理后,肝脏胞质溶胶中谷胱甘肽S-转移酶的表观同工酶组成发生了变化。在未处理大鼠的肝脏胞质溶胶中观察到谷胱甘肽S-转移酶AA、A、B、C和D + E;相反,与碱性谷胱甘肽S-转移酶(如AA、A、B和C)相关的催化活性在氯仿处理后随时间降低。氯仿处理2小时后未检测到谷胱甘肽S-转移酶B,5小时后谷胱甘肽S-转移酶AA和C几乎检测不到。氯仿处理24小时后,谷胱甘肽S-转移酶A和C以及D + E和少量B均可清晰检测到。氯仿处理可降低肝脏胞质溶胶谷胱甘肽S-转移酶活性,并在处理后5小时降至最低。与肝脏胞质溶胶谷胱甘肽S-转移酶活性降低相对应,血清谷胱甘肽S-转移酶活性在氯仿处理后5小时达到最大升高,并在24小时时恢复到几乎正常水平。用SKF 525-A或半胱氨酸处理大鼠可抑制氯仿诱导的血清谷胱甘肽S-转移酶活性升高。血清中存在的谷胱甘肽S-转移酶的色谱特性与谷胱甘肽S-转移酶D + E相似。此外,在肝微粒体和NADPH存在下,将部分纯化的胞质溶胶谷胱甘肽S-转移酶与氯仿一起孵育后,仅检测到转移酶D + E。向部分纯化的胞质溶胶谷胱甘肽S-转移酶中加入胆红素可降低谷胱甘肽S-转移酶B和C的碱性。总之,氯仿导致肝脏胞质溶胶谷胱甘肽S-转移酶释放到血清中。由微粒体细胞色素P-450系统产生的氯仿活性代谢物以及因氯仿处理而增加的胆红素均在改变谷胱甘肽S-转移酶的特性中起作用。